Masimo(MASI)
IRVINE, CAMedical Devices
Focus: Masimo is a mid-cap medical device company headquartered in Irvine, CA, specializing in noninvasive monitoring technologies including pulse oximetry, CO-oximetry, and NIRS/EEG systems. With 5,001–10,000 employees and $1.3B in FY 2025 revenue, it operates as a publicly traded (MASI) player in the global patient monitoring market.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
5001-10000
Open Jobs
1
Should You Work at Masimo?
AI assessmentMasimo offers stable, device-focused R&D employment with established market position, but recent financial contraction and minimal open headcount suggest limited near-term expansion opportunities.
Why Work Here
- Stable, profitable public company with $82M net income (FY 2025) and $124M cash providing employment security
- R&D-driven device innovator with $131M annual R&D spend (10% of revenue) focused on next-generation monitoring sensors and algorithms
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$1.3B
Pipeline & Clinical Trials
INVSENSOR00026
HealthyClinical Trials (1)
NCT03677375Hemodilution Validation of INVSENSOR00026
N/AHelp build intelligence for Masimo
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.